ArticleCancers2025

Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer.

Guojing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.